Palisade Bio (PALI) Receivables (2011 - 2023)

Palisade Bio (PALI) reported Receivables of $300000.0 for Q1 2023, up 112.39% quarter-over-quarter from $141250.0 in Q4 2022.

Palisade Bio (PALI) Receivables (2011 - 2023) Analysis & Trends

Palisade Bio (PALI) has 13 years of Receivables data on file, last reported at $300000.0 in Q1 2023.

  • Receivables for Q1 2023 came in at $300000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2023 was $300000.0 (changed N/A YoY), and the FY2022 annual result was $141250.0, changed N/A from the prior year.
  • Receivables improved to $300000.0 in Q1 2023 per PALI's latest filing, from $141250.0 in the prior quarter.
  • Over five years, Receivables peaked at $466782.0 in Q1 2019 and troughed at $21064.0 in Q4 2019.
  • A 5-year average of $226845.4 and a median of $246976.0 in 2020 frame the typical range for Receivables.
  • The sharpest annual moves came in 2019 and 2020: Receivables sank 94.12% in 2019, then soared 1267.26% in 2020.
  • A 5-year view of Receivables shows it stood at $21064.0 in 2019, then soared by 1267.26% to $288000.0 in 2020, then plunged by 79.51% to $59000.0 in 2021, then jumped by 139.41% to $141250.0 in 2022, then soared by 112.39% to $300000.0 in 2023.
  • Business Quant data shows PALI's Receivables at $300000.0 in Q1 2023, $141250.0 in Q4 2022, and $59000.0 in Q2 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 13.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 2.00 Bn
9 Abivax 91.96 Bn 91.96 Bn - -
10 Palisade Bio 391.02 Mn 261.45 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2023 300,000.00
Dec 31, 2022 141,250.00
Jun 30, 2021 59,000.00
Mar 31, 2021 25,259.00
Dec 31, 2020 288,000.00
Sep 30, 2020 237,779.00
Jun 30, 2020 245,938.00
Mar 31, 2020 248,014.00
Dec 31, 2019 21,064.00
Sep 30, 2019 290,154.00
Jun 30, 2019 398,905.00
Mar 31, 2019 466,782.00
Dec 31, 2018 357,995.00
Sep 30, 2018 224,227.00
Jun 30, 2018 478,722.00
Mar 31, 2018 137,372.00
Dec 31, 2017 371,586.00
Sep 30, 2017 595,458.00
Jun 30, 2017 563,345.00
Mar 31, 2017 572,715.00